|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1400 - 0.1400|
|52 Week Range||0.0210 - 0.2200|
|Beta (5Y Monthly)||0.15|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
KING OF PRUSSIA, PA / ACCESSWIRE / August 4, 2020 / Emergent Health Corp.
KING OF PRUSSIA, PA / ACCESSWIRE / May 26, 2020 / Emergent Health Corp. (the "Company") (OTC PINK:EMGE) purpose of this Press Release is to further update our shareholders on its CancX® Nutritional Support for Cancer patients. Each participant completed an Informed Consent Agreement and Questionnaires for up to 4 weeks.
1.The Company, through its direct and indirect subsidiaries, Emergent Medical Foods, Inc. and Emergent OTC Products, Inc. is in the process of designing NutraCan™ Nutritional Support and activating CancX® Nutritional Support to respective distribution channels. The Company is proud of these Cancer Support advances and expects even better health and financial results to develop over time. 2.The Company expects to introduce a new product to relieve stress.